Navigation Links
Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
Date:12/13/2012

nd uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products. In addition, sales of our products are affected by reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We, or others, could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 Konica ... achieved record sales growth for fiscal year ended ... digital radiography family of Primary Imaging Solutions.  The ... fueled company growth to double digit sales figures ... solutions includes the AeroDR XE, a wireless flat ...
(Date:4/28/2015)... 28, 2015  nUro, Inc. (the "Company") announced ... invest in Rosellini Scientific Benelux, SPRL. This marks the ... equity injections and one acquisition). nUro, Inc. plans to ... rapid prototyping labs in Wallonia and in conjunction ... investment comes in conjunction with notice of an ...
(Date:4/28/2015)... BIRMINGHAM, Ala. , April 28, 2015 /PRNewswire/ ... solution company for quickly and accurately capturing complete ... introduces the rebranding of its software platform to ... learns and simplifies what surgeons need to successfully ... unreasonable and unacceptable burden on surgeons to micro-dictate ...
Breaking Medicine Technology:Konica Minolta Sets Record Digital Radiography Sales 2nUro, Inc. Invests in Wallonia-Based Medtech Company 2nUro, Inc. Invests in Wallonia-Based Medtech Company 3nUro, Inc. Invests in Wallonia-Based Medtech Company 4Vincari introduces Lightspeed Valet, a web and mobile software solution for delivering ICD-10 surgical documentation at the point-of-care with extreme speed and accuracy 2
... 3, 2011 Clinicians may soon have a new tool ... – one of the most common sexually transmitted infections in ... and Company) (NYSE: BDX ), announced today that ... clearance for the first fully automated molecular tests to diagnose ...
... 2011 See video from Endo Pharmaceuticals at: ... The FDA has approved Fortesta™ (testosterone) ... low testosterone or "Low T," a condition that ... States. Available content includes an audio news release, ...
Cached Medicine Technology:New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
(Date:4/28/2015)... California (PRWEB) April 28, 2015 ... Skin Concierge have developed a new, online acne ... for acne sufferers using their specialized acne mapping ... anywhere in the state of California with internet ... need to travel to a physical office. The ...
(Date:4/28/2015)... FL (PRWEB) April 28, 2015 Two ... System were named to Becker's Hospital Review’s list ... . Peter Pronovost, M.D., Ph.D. , director of ... and senior vice president for patient safety and ... M.D., M.H.C.M. , vice president of medical affairs and ...
(Date:4/28/2015)... 28, 2015 The popular all-natural supplement ... for their newly launched L-Style Revolution Program™, and collectively ... counting in just two short months. The customized ... exercise plan for men and women of all health ... loss and weight maintenance goals faster than traditional methods. ...
(Date:4/28/2015)... April 28, 2015 An Allegheny ... A. Jobe, MD, FACS , has launched the first ... with extracellular matrix (ECM) can help patients who are ... esophageal cancer. , ECM is a complex mixture of ... and migration and signals that guide cell behavior. ECM, ...
(Date:4/28/2015)... 28, 2015 As the Muscular ... healthcare services programs, the organization has hired Scientific ... to MDA from Fidelity Biosciences Research Initiative where, ... projects in neurodegenerative diseases such as Alzheimer’s Disease, ... her time at Fidelity, she was a junior ...
Breaking Medicine News(10 mins):Health News:New Online Acne Treatment Service for California 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 4Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3
... of the National Academy of Science, scientists have found ... work of an enzyme that insects’ immune systems use ... so-called gene-for-gene interactions are thought to be common in ... a pathogen targeting a single gene in an animal ...
... common, affecting one in 70 schoolchildren, available data says. The ... ,A joint team of scientists from the King's ... are taking up a seven-year study and hope to rope ... babies being studied are between four and 11 months and ...
... is no dearth of "anti-aging" products and surgeries// in the ... go for them not just to enhance their looks, but ... enough in the market place, many observers point out. ... The toxin blocks the transmission of acetylcholine from the nerves ...
... in the US. A Defence Department panel has warned ... serious challenge on two fronts. ,One, soldiers are ... at the current level of staffing and funds, the military ... necessary statement. ,In a damning revelation, the ...
... who lost their lives to work- related cancers and heart ... new labor laws state that they no// longer need to ... compensation due the dead worker’s family. , ... that will be presumed to have been work-related when contracted ...
... on Tuesday launched a campaign to encourage Hispanics to ... rate for U.S. Hispanics increased from 11.6% in 1991 ... to be obese and two times more likely to ... AP/Star reports. ,LNC's campaign features a ...
Cached Medicine News:Health News:Scientists Discover Rare ‘gene-for-gene’ Interaction That Helps Bacteria Kill Their Ho 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: